• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

牙源性角化囊性瘤中的细胞增殖与凋亡

Cell proliferation and apoptosis in keratocystic odontogenic tumors.

作者信息

Mateus Gláucia Cardoso Paixão, Lanza Gleyson Henrique dos Santos Pena, de Moura Pedro Henrique Ribeiro, Marigo Helenice de Andrade, Horta Martinho Campolina Rebello

机构信息

Oral Pathology Laboratory, School of Dentistry, Pontifícia Universidade Católica de Minas Gerais, Belo Horizonte, MG, Brazil.

出版信息

Med Oral Patol Oral Cir Bucal. 2008 Nov 1;13(11):E697-702.

PMID:18978709
Abstract

OBJECTIVES

Keratocystic odontogenic tumors (KOTs), also known as odontogenic keratocysts, were recently classified as a benign neoplasia due to the aggressive clinical behavior. Although several studies have shown the high proliferative activity of the epithelial lining, few studies have evaluated apoptosis in KOTs. Therefore, the aim of this study is to evaluate and compare the proliferation index (PI) and the apoptotic index (AI) of the epithelial lining in sporadic KOTs, KOTs associated with the Nevoid Basal Cell Carcinoma Syndrome (NBCCS KOTs), and dentigerous cysts.

MATERIAL AND METHODS

A total of 11 sporadic KOTs, 15 NBCCS KOTs, and 11 dentigerous cysts were evaluated. The PI was assessed by immunohistochemical detection of the cell proliferation marker Ki-67. The AI was assessed by morphological evaluation of sections stained by methyl green-pyronin. The TUNEL assay was used to confirm the occurrence of apoptosis. Differences in the PI and the AI between sporadic KOTs, NBCCS KOTs, and dentigerous cysts were analyzed using the Kruskal-Wallis test. Differences in the PI and the AI between the epithelial layers of each lesion were analyzed using the Wilcoxon test.

RESULTS

The PI and AI were higher in sporadic and NBCCS KOTs than in dentigerous cysts. No difference in these indexes was observed between sporadic and NBCCS KOTs. In dentigerous cysts, the PI was higher in the basal layer. In sporadic and NBCCS KOTs, the PI was higher in suprabasal layer. No difference in the AI was observed between the basal layer and the suprabasal layer in the three lesions. The AI was higher in the superficial layer of sporadic and NBCCS KOTs.

CONCLUSIONS

The present study demonstrates that the epithelial lining of KOTs shows a distinct pattern of cell proliferation and apoptosis, reflecting its high cell turnover and reinforcing its classification as an odontogenic tumor.

摘要

目的

角化囊性牙源性肿瘤(KOTs),也称为牙源性角化囊肿,因其侵袭性临床行为最近被归类为良性肿瘤。尽管多项研究表明其上皮衬里具有高增殖活性,但很少有研究评估KOTs中的细胞凋亡情况。因此,本研究的目的是评估和比较散发性KOTs、与痣样基底细胞癌综合征相关的KOTs(NBCCS KOTs)以及含牙囊肿中上皮衬里的增殖指数(PI)和凋亡指数(AI)。

材料与方法

共评估了11例散发性KOTs、15例NBCCS KOTs和11例含牙囊肿。通过免疫组织化学检测细胞增殖标志物Ki-67来评估PI。通过对甲基绿-派洛宁染色切片进行形态学评估来评估AI。采用TUNEL法确认细胞凋亡的发生。使用Kruskal-Wallis检验分析散发性KOTs、NBCCS KOTs和含牙囊肿之间PI和AI的差异。使用Wilcoxon检验分析每个病变上皮层之间PI和AI的差异。

结果

散发性和NBCCS KOTs中的PI和AI高于含牙囊肿。散发性和NBCCS KOTs之间在这些指标上未观察到差异。在含牙囊肿中,基底层的PI较高。在散发性和NBCCS KOTs中,基底上层的PI较高。在这三种病变的基底层和基底上层之间未观察到AI的差异。散发性和NBCCS KOTs表层的AI较高。

结论

本研究表明,KOTs的上皮衬里显示出独特的细胞增殖和凋亡模式,反映了其高细胞更新率,并强化了其作为牙源性肿瘤的分类。

相似文献

1
Cell proliferation and apoptosis in keratocystic odontogenic tumors.牙源性角化囊性瘤中的细胞增殖与凋亡
Med Oral Patol Oral Cir Bucal. 2008 Nov 1;13(11):E697-702.
2
Immunohistochemical analysis of the biological potential of odontogenic keratocysts.牙源性角化囊肿生物学潜能的免疫组织化学分析
J Oral Pathol Med. 2006 Feb;35(2):75-80. doi: 10.1111/j.1600-0714.2006.00382.x.
3
Analysis of the neoplastic nature and biological potential of sporadic and nevoid basal cell carcinoma syndrome-associated keratocystic odontogenic tumor.散发性及痣样基底细胞癌综合征相关牙源性角化囊性瘤的肿瘤性质及生物学潜能分析
J Oral Pathol Med. 2007 Oct;36(9):550-4. doi: 10.1111/j.1600-0714.2007.00578.x.
4
Expression of cell cycle and apoptosis-related proteins in ameloblastoma and keratocystic odontogenic tumor.成釉细胞瘤和牙源性角化囊性瘤中细胞周期及凋亡相关蛋白的表达
Ann Diagn Pathol. 2013 Dec;17(6):518-21. doi: 10.1016/j.anndiagpath.2013.06.006. Epub 2013 Oct 1.
5
Immunolocalisation of laminin-1 in keratocystic odontogenic tumors.层粘连蛋白-1 在牙源性角化囊性瘤中的免疫定位。
Acta Histochem. 2010 Nov;112(6):624-9. doi: 10.1016/j.acthis.2009.06.006. Epub 2009 Sep 20.
6
Keratocystic odontogenic tumor associated with nevoid basal cell carcinoma syndrome: similar behavior to sporadic type?牙源性角化囊性瘤伴结节性基底细胞痣黑色素瘤综合征:与散发型有相似行为?
Otolaryngol Head Neck Surg. 2010 Feb;142(2):179-83. doi: 10.1016/j.otohns.2009.10.008.
7
Beta-catenin and survivin expression in keratocystic odontogenic tumor (KCOT). A comparative immunohistochemical study in primary, recurrent and nevoid basal cell carcinoma syndrome (NBCCS)-associated lesions.β-连环蛋白和存活素在牙源性角化囊性瘤(KCOT)中的表达。原发性、复发性和痣样基底细胞癌综合征(NBCCS)相关病变的比较免疫组织化学研究。
Histol Histopathol. 2013 Sep;28(9):1175-84. doi: 10.14670/HH-28.1175. Epub 2013 Apr 10.
8
Odontogenic epithelium: immunolabeling of Ki-67, EGFR and survivin in pericoronal follicles, dentigerous cysts and keratocystic odontogenic tumors.牙源性上皮:冠周滤泡、含牙囊肿及牙源性角化囊性肿瘤中Ki-67、表皮生长因子受体(EGFR)和生存素的免疫标记
Head Neck Pathol. 2011 Mar;5(1):1-7. doi: 10.1007/s12105-010-0216-0. Epub 2010 Oct 30.
9
Actual Proliferating Index and p53 protein expression as prognostic marker in odontogenic cysts.实际增殖指数和p53蛋白表达作为牙源性囊肿的预后标志物
Oral Dis. 2009 Oct;15(7):490-8. doi: 10.1111/j.1601-0825.2009.01590.x. Epub 2009 Jun 26.
10
Expression of podoplanin in nevoid basal cell carcinoma syndrome-associated keratocystic odontogenic tumours.棘皮瘤蛋白在结节性基底细胞癌综合征相关角化囊性牙源性肿瘤中的表达。
Anticancer Res. 2012 May;32(5):2125-7.

引用本文的文献

1
Glucose transporter 1 expression in ameloblastoma and odontogenic keratocyst - A comparative immunohistochemical study.成釉细胞瘤和牙源性角化囊肿中葡萄糖转运蛋白1的表达——一项免疫组织化学对比研究
J Oral Maxillofac Pathol. 2022 Apr-Jun;26(2):185-191. doi: 10.4103/jomfp.jomfp_9_21. Epub 2022 Jun 28.
2
The immunohistochemical profile of basal cell nevus syndrome-associated and sporadic odontogenic keratocysts: a systematic review and meta-analysis.基底细胞痣综合征相关和散发性牙源性角化囊肿的免疫组织化学特征:系统评价和荟萃分析。
Clin Oral Investig. 2021 Jun;25(6):3351-3367. doi: 10.1007/s00784-021-03877-w. Epub 2021 Mar 17.
3
Maspin, Syndecan-1, and Ki-67 in the Odontogenic Keratocyst: An Immunohistochemical Analysis.
牙源性角化囊肿中Maspin、Syndecan-1和Ki-67的免疫组织化学分析
Int J Dent. 2020 Jul 14;2020:7041520. doi: 10.1155/2020/7041520. eCollection 2020.
4
Computerized Evaluation of the Immunoexpression of Ki-67 Protein in Odontogenic Keratocyst and Dentigerous Cyst.计算机化评估 Ki-67 蛋白在牙源性角化囊肿和含牙囊肿中的免疫表达。
Head Neck Pathol. 2020 Sep;14(3):598-605. doi: 10.1007/s12105-019-01077-3. Epub 2019 Sep 24.
5
p53, p63 and p73 expression and angiogenesis in keratocystic odontogenic tumors.牙源性角化囊性瘤中p53、p63和p73的表达与血管生成
J Clin Exp Dent. 2016 Dec 1;8(5):e505-e511. doi: 10.4317/jced.52843. eCollection 2016 Dec.
6
Histochemical detection and comparison of apoptotic cells in the gingival epithelium using hematoxylin and eosin and methyl green-pyronin: A pilot study.使用苏木精-伊红染色和甲基绿-派洛宁对牙龈上皮细胞凋亡进行组织化学检测及比较:一项初步研究。
J Indian Soc Periodontol. 2016 May-Jun;20(3):294-8. doi: 10.4103/0972-124X.182601.
7
Metallothionein immunoexpression in non-syndromic and syndromic keratocystic odontogenic tumour.非综合征型和综合征型牙源性角化囊性瘤中的金属硫蛋白免疫表达
Med Oral Patol Oral Cir Bucal. 2015 Jul 1;20(4):e408-12. doi: 10.4317/medoral.20418.
8
Evaluation and comparison of expression of p63 in odontogenic keratocyst, solid ameloblastoma and unicystic ameloblastoma.p63在牙源性角化囊肿、实性成釉细胞瘤和单囊性成釉细胞瘤中的表达评估与比较。
J Oral Maxillofac Pathol. 2014 May;18(2):223-8. doi: 10.4103/0973-029X.140755.
9
The relation of pericoronal third molar follicle dimension and bcl-2/ki-67 expression: An immunohistochemical study.冠周第三磨牙滤泡大小与bcl-2/ki-67表达的关系:一项免疫组织化学研究。
Dent Res J (Isfahan). 2012 Dec;9(Suppl 1):S26-31. doi: 10.4103/1735-3327.107931.
10
Exploring the concept of "inflammatory angiogenesis" in keratocystic odontogenic tumor.探讨牙源性角化囊性瘤中“炎症性血管生成”的概念。
Med Oral Patol Oral Cir Bucal. 2013 Mar 1;18(2):e241-5. doi: 10.4317/medoral.18351.